human-papillomavirus

Documents about human-papillomavirus

• Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women#906871ClinicalTrials.gov
• Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance#968345ClinicalTrials.gov
• Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)#148553ClinicalTrials.gov
• Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine#184932ClinicalTrials.gov
• Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi#201600ClinicalTrials.gov
• Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19: Mixed Methods Retrospective Cross-Sectional Study.#214160NCBI PubMed Central
• The Influence of Social Media Messaging on Human Papillomavirus Vaccine Attitudes and Confidence Among Adolescent Males: Group Discussion Study.#297406NCBI PubMed Central
• A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)#394626ClinicalTrials.gov
• Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)#405202ClinicalTrials.gov
• Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)#448302ClinicalTrials.gov
• PREVALENCE OF HUMAN PAPILLOMAVIRUS IN ORAL AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS#619382CyberLeninka
• Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens#833801ClinicalTrials.gov
• Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)#350022ClinicalTrials.gov
• Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology#889179ClinicalTrials.gov
• A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects#67707ClinicalTrials.gov
• Impact of Interventions to Improve Human Papillomavirus Vaccine Uptake on Other Vaccines Due: A Secondary Analysis of a Randomized Trial.#266953NCBI PubMed Central
• Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia.#396048NCBI PubMed Central
• Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years#448303ClinicalTrials.gov
• Dynamic changes of HPV genotypes in a tourism-influenced populated area, Northeastern Iran#646442PLOS
• Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix#845659ClinicalTrials.gov
• Chinese Cancer Prevention Study(CHICAPS)#979325ClinicalTrials.gov
• Placental HPV Infection in HIV Positive and HIV Negative Zambian Women#982879DigitalCommons@University of Nebraska
• Prevalence and determinants of parental refusal of human papillomavirus vaccination in Morocco: A multicenter cross-sectional study#161662Unpaywall
• The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men#329569ClinicalTrials.gov
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers#356487ClinicalTrials.gov
• A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates#827954ClinicalTrials.gov
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)#911011ClinicalTrials.gov
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection#882688ClinicalTrials.gov
• REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)#869872ClinicalTrials.gov
• Potential health impact and cost-effectiveness of human papillomavirus vaccination in Tunisia: A comparative modeling study#312112HAL (France)
• Micro-Costing Analysis for Human Papillomavirus (HPV) Vaccination Services for Out-of-School (OOS) Girls in Indonesia: Evidence from a Pilot Study#405076bioRxiv / medRxiv
• How practically feasible is tailored screening for cervical cancer based on human papillomavirus vaccination status?: the role of data linkage and registers.#630918NCBI PubMed Central
• The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan#801523ClinicalTrials.gov
• Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta#883745ClinicalTrials.gov
• Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis#955580Koc University Digital Collections
• Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment#981946ClinicalTrials.gov
• Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study.#1039983NCBI PubMed Central
• Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement#1046193ClinicalTrials.gov
• A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls#835987ClinicalTrials.gov
• Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)#854239ClinicalTrials.gov
• FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women#129238PMC Full-Text (OAI)
• Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy#174942ClinicalTrials.gov
• Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study#234497ClinicalTrials.gov
• Performance Feedback for Human Papillomavirus Vaccination: A Randomized Trial From the American Academy of Pediatrics Pediatric Research in Office Settings Research Network.#340652NCBI PubMed Central
• Quality of life in women with a human papillomavirus-positive screening test, cervical neoplasia, or cervical cancer in Latin America#438540bioRxiv / medRxiv
• County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana#854753ClinicalTrials.gov
• The Efficacy of Reminders to Complete HPV Series#868196ClinicalTrials.gov
• Parental knowledge, socioeconomic factors and barriers to HPV vaccination uptake among children in Lebanon: a cross-sec#5147Europe PMC
• Human Papillomavirus vaccine knowledge and recommendation practice among primary care providers, Almaty, Kazakhstan - 2023#5151Europe PMC
• An entropy-based framework for genomic variability analysis: A South American case study of human papillomavirus#187825PLOS